Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Gene variants associated with blood type may contribute to risk of early stroke

Gene variants associated with a person's blood type may be linked to their risk of early stroke, according to a new meta-analysis published in the August 31, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

1 Sep 2022

Type 2 diabetes remission achieved more effectively with bariatric surgery than lifestyle changes

Remission of type 2 diabetes is achieved more effectively and has longer-lasting results with bariatric surgery than through medications and lifestyle changes.

1 Sep 2022

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

The prevalence and risk factors for delirium in older patients hospitalized with COVID-19

A recent study explored what determined the risk of delirium in older patients hospitalized with COVID-19 and the outcomes of this hospitalization.

31 Aug 2022

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Recent breakthroughs have revealed a great deal about Alzheimer's disease, but researchers have yet to paint a complete picture of how genetic risk for the illness causes the brain damage that ultimately leads to memory loss and cognitive decline.

30 Aug 2022

Research shows how sensor-based health monitoring could help tackle age-related health problems

Specific changes in our movement patterns can be indicators of several health problems: For instance, decrease in strength often correlates with risk of falls, mild cognitive impairment, depression, sleep problems, respiratory problems, cardiac arrhythmias and increasing myocardial weakness or worsening of a COVID-19 infection.

30 Aug 2022

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

α-synuclein is a neuronal protein involved in functions like vesicle trafficking and neurotransmitter release. It is typically found in abundance in a healthy brain.

30 Aug 2022

Study sheds new light on the nature of balance deficits in neurocognitive disorders

Balance is important to maintain in many aspects of life, but the most important may be your body's sense of balance—also known as vestibular sense—which keeps you upright when moving or standing.

30 Aug 2022

Study moves one step closer to providing a more efficient treatment for age-related memory loss

According to the Alzheimer's Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's in 2022. That figure is predicted to nearly double by 2050.

29 Aug 2022

Regenstrief research scientist voted president-elect of the American Delirium Society

Regenstrief Research Scientist Noll Campbell, PharmD, M.S., has been voted president-elect of the American Delirium Society (ADS) by the board of directors. Dr. Campbell will be installed into office in conjunction with the society's national conference in June of 2023.

29 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

Alzheimer's disease (AD) is the most common type of dementia affecting an estimated 6.3 million Americans age 65 and older. Without the development of medical breakthroughs to prevent, treat, slow or cure AD that number could grow to 13.8 million by 2060.

29 Aug 2022

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Neurodegenerative disorders such as Alzheimer's and Parkinson's disease are associated with atypical proteins that form tangles in the brain, killing neurons.

29 Aug 2022

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

As populations around the globe age, dementia -; often caused by Alzheimer's disease and related disorders -; is a growing health issue for older adults worldwide.

26 Aug 2022

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Dr. Anaїs Rameau, an assistant professor of otolaryngology and an attending laryngologist at the Sean Parker Institute for the Voice at Weill Cornell Medicine, has been awarded a Paul B. Beeson Emerging Leaders Career Development Award in Aging by the National Institute on Aging, the American Federation for Aging Research and the John A. Hartford Foundation.

26 Aug 2022

Sacubitril/valsartan does not change cognitive function in patients with heart failure

Sacubitril/valsartan does not change cognitive function, compared with valsartan, in patients with heart failure and mildly reduced or preserved ejection fraction, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

26 Aug 2022

UC Davis research reveals a novel role for how tau functions in healthy nerve cells

In Alzheimer's Disease and other neurodegenerative dementias, proteins that normally play a role in healthy brain tissue turn bad, clumping together to form insoluble plaques and tangles as neurons wither and die.

25 Aug 2022

Brain stimulation improves memory function in older adults

Researchers evaluate the effectiveness of repetitive neuromodulation in improving the working memory and long-term memory of older adults.

25 Aug 2022

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.

25 Aug 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Gene variants associated with blood type may contribute to risk of early stroke

Type 2 diabetes remission achieved more effectively with bariatric surgery than lifestyle changes

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

The currently available evidence on viral-induced parkinsonism

The prevalence and risk factors for delirium in older patients hospitalized with COVID-19

Study uncovers molecular changes in the brain’s blood vessels caused by Alzheimer’s susceptibility gene

Research shows how sensor-based health monitoring could help tackle age-related health problems

In vivo imaging of α-synuclein aggregates in the brains of living patients with multiple system atrophy

Study sheds new light on the nature of balance deficits in neurocognitive disorders

Study moves one step closer to providing a more efficient treatment for age-related memory loss

Regenstrief research scientist voted president-elect of the American Delirium Society

Music intervention can help bridge the gap between dementia patients and their loved ones

FAU and Tel Aviv researchers receive grant to tackle Alzheimer’s-related mood disorders

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

Weill Cornell Medicine laryngologist wins Paul B. Beeson Emerging Leaders Career Development Award in Aging

Sacubitril/valsartan does not change cognitive function in patients with heart failure

UC Davis research reveals a novel role for how tau functions in healthy nerve cells

Brain stimulation improves memory function in older adults

New diagnoses of neurological and psychiatric disorders remain common two years after COVID-19

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in